Biotech

Latest Articles

Kailera launches with $400M collection A, 4 Mandarin excessive weight medicines

.Kailera Rehabs has actually released in to the significantly jampacked weight problems area with a ...

Metsera partner with Amneal to lock down GLP-1 source

.Along with very early stage 1 data right now out in bush, metabolic illness attire Metsera is throw...

Rivus blog posts records to back up muscle-sparing obesity drug claims

.Rivus Pharmaceuticals has introduced the information behind its stage 2 weight problems gain in hea...

BMS spends $110M to create T-cell treatment treaty, aiding Prime buy time to improve prioritized pipeline

.Bristol Myers Squibb is paying Best Medicine $110 thousand upfront to develop reagents for ex-boyfr...

Generate increases yet another $1B-plus Major Pharma partnership

.Novartis has tattooed an offer likely worth more than $1 billion with Flagship-founded Generate: Bi...

Metsera GLP-1 data slice shows 7.5% weight management at 36 times

.Recently debuted Metsera is unfolding some period 1 record for its own GLP-1 receptor agonist, show...

Flagship hopes biotechs flock to Mirai to enhance hereditary meds

.Amid the hereditary medications branches nationality, Flagship Pioneering is actually introducing a...

BioAge eyes $180M coming from IPO, personal positioning for excessive weight tests

.BioAge Labs is looking at all around $180 million in preliminary profits from an IPO as well as a p...

Merck's LAG-3 combo stops working colorectal cancer phase 3 research

.An attempt through Merck &amp Co. to open the microsatellite dependable (MSS) metastatic colorectal...

Spanish VC finalizes $200M life sciences fund

.Spain-based Asabys Allies has actually finalized a fund of 180 million euros ($ 200 thousand), mone...

BioAge brings in $198M coming from IPO as obesity biotech signs up with Nasdaq

.BioAge Labs is bringing in virtually $200 thousand through its own Nasdaq IPO today, with the earni...

Acadia brings BMS veterinarian on board as chief executive officer-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of considerable management hirings, firings...

Cassava spends $40M over supposedly confusing Alzheimer's update

.Cassava Sciences has actually consented to pay $40 thousand to address an examination in to cases i...

Merck bags alternatives on Evaxion's AI-designed vaccination candidates

.Merck &amp Co. has actually gotten alternatives on 2 Evaxion Biotech vaccine candidates, paying for...

Enanta's RSV antiviral crushes viral tons in problem research

.Enanta Pharmaceuticals has connected its respiratory system syncytial infection (RSV) antiviral to ...

Biogen cans SAGE-324 partnership after necessary shake neglect

.Biogen has actually conducted the final rites to its own collaboration along with Sage Rehabs on SA...

AbbVie Parkinson's drug coming from $8.7 B Cerevel purchase credit ratings

.On the exact same time that some Parkinson's illness drugs are actually being brought into question...

Arch finalizes $3B-plus fund to cultivate biopharma upstarts

.On the heels of a $3 billion fund from Bain Financing Life Sciences, Arch Venture Allies is proving...

Orion to make use of Aitia's 'electronic doubles' to discover brand new cancer medicines

.Finnish biotech Orion has actually spied prospective in Aitia's "digital double" technology to cult...

Windtree's shock med brings up high blood pressure in latest period 2 win

.While Windtree Therapeutics has actually had a hard time to increase the financial roots required t...